HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danqing Kong Selected Research

Acquired amegakaryocytic thrombocytopenia

8/2022Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danqing Kong Research Topics

Disease

1Acquired amegakaryocytic thrombocytopenia
08/2022
1Lymphoma (Lymphomas)
01/2022
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022
1Residual Neoplasm
10/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020
1Cytokine Release Syndrome
01/2020
1Neoplasms (Cancer)
01/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020
1Anemia
01/2018

Drug/Important Bio-Agent (IBA)

2eltrombopagFDA Link
08/2022 - 01/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
08/2022
1Bortezomib (Velcade)FDA Link
01/2022
1Chimeric Antigen ReceptorsIBA
01/2020
1Thrombopoietin ReceptorsIBA
01/2018
1Prostaglandins FIBA
01/2018

Therapy/Procedure

2Therapeutics
10/2020 - 01/2020